𝔖 Bobbio Scriptorium

✦ LIBER ✦

Multicenter, randomized, double-blind, vehicle-controlled, dose-ranging study to evaluate the efficacy and safety of PEP005 (ingenol mebutate) gel 0.005%, 0.01%, and 0.015% when used to treat actinic keratoses on the head

Book ID: 116586363
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 46 KB
Volume: 62
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2009.11.416

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multicenter, randomized, parallel-group,

Multicenter, randomized, parallel-group, double-blind, vehicle-controlled study to evaluate the efficacy and safety of PEP005 (ingenol mebutate) gel, 0.05% in patients with actinic keratoses on nonhead locations

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Multicenter, open-label, dose-area escal

Multicenter, open-label, dose-area escalation, cohort study to evaluate the safety and tolerability of PEP005 (ingenol mebutate) gel 0.05% applied for two consecutive days to treatment area(s) of up to a total of 100cm2 in patients with actinic keratoses

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Vehicle-controlled, randomized, double-b

Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head

✍ A. Alomar; J. Bichel; S. McRae 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 546 KB